文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

社论：2021 年欧洲心脏病学会（ESC）关于动脉粥样硬化性心血管疾病（ASCVD）真实世界预防的指南。

Editorial: The 2021 European Society of Cardiology (ESC) Guidelines on the Real-World Prevention of Atherosclerotic Cardiovascular Disease (ASCVD).

机构信息

Science Editor, Medical Science Monitor, International Scientific Information, Inc., Melville, NY, USA.

出版信息

Med Sci Monit. 2021 Oct 25;27:e935172. doi: 10.12659/MSM.935172.

DOI:10.12659/MSM.935172
PMID:34690345
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8555443/
Abstract

Some of the most challenging guidelines for clinical practice include recommendations for disease prevention, which often involve lifestyle modifications, which may vary between populations. On August 30, 2021, the European Society of Cardiology (ESC) published new guidelines for primary and secondary prevention of atherosclerotic cardiovascular disease (ASCVD), endorsed by 12 European professional societies. Important features of the 2021 ESC guidelines include recommendations for disease prevention in individuals in clinical practice, including in older adults, with and without ASCVD, with diabetes, familial hypercholesterolemia, and chronic kidney disease (CKD). Importantly, and for the first time, the updated 2021 ESC guidelines also address the impact of environmental factors, including water, air, and soil pollution, on the risk of ASCVD. This Editorial aims to present and discuss how the latest 2021 ESC guidelines on the prevention of ASCVD have practical real-world applications in clinical practice.

摘要

一些最具挑战性的临床实践指南包括疾病预防建议，这些建议通常涉及生活方式的改变，而这些改变在不同人群中可能有所不同。2021 年 8 月 30 日，欧洲心脏病学会（ESC）发布了动脉粥样硬化性心血管疾病（ASCVD）一级和二级预防的新指南，得到了 12 个欧洲专业学会的认可。2021 ESC 指南的重要特点包括为临床实践中的个体，包括老年人、有和没有 ASCVD、糖尿病、家族性高胆固醇血症和慢性肾脏病（CKD）的个体提供疾病预防建议。重要的是，也是首次，更新的 2021 ESC 指南还解决了环境因素（包括水、空气和土壤污染）对 ASCVD 风险的影响。本社论旨在介绍和讨论最新的 2021 ESC ASCVD 预防指南在临床实践中的实际应用。

相似文献

[1]
Editorial: The 2021 European Society of Cardiology (ESC) Guidelines on the Real-World Prevention of Atherosclerotic Cardiovascular Disease (ASCVD).

Med Sci Monit. 2021-10-25

[2]
European Society of Cardiology Quality Indicators for Cardiovascular Disease Prevention: developed by the Working Group for Cardiovascular Disease Prevention Quality Indicators in collaboration with the European Association for Preventive Cardiology of the European Society of Cardiology.

Eur J Prev Cardiol. 2022-5-25

[3]
Statin Use in Primary Prevention of Atherosclerotic Cardiovascular Disease According to 5 Major Guidelines for Sensitivity, Specificity, and Number Needed to Treat.

JAMA Cardiol. 2019-11-1

[4]
Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines for cardiovascular disease prevention in a European cohort.

JAMA. 2014-4-9

[5]
Comparison of ACC/AHA and ESC Guideline Recommendations Following Trial Evidence for Statin Use in Primary Prevention of Cardiovascular Disease: Results From the Population-Based Rotterdam Study.

JAMA Cardiol. 2016-9-1

[6]
Atherosclerotic cardiovascular disease risk assessment: An American Society for Preventive Cardiology clinical practice statement.

Am J Prev Cardiol. 2022-3-15

[7]
2019 vs. 2016 ESC/EAS statin guidelines for primary prevention of atherosclerotic cardiovascular disease.

Eur Heart J. 2020-8-14

[8]
Retrospective examination of lipid-lowering treatment patterns in a real-world high-risk cohort in the UK in 2014: comparison with the National Institute for Health and Care Excellence (NICE) 2014 lipid modification guidelines.

BMJ Open. 2017-2-17

[9]
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE.

Endocr Pract. 2017-4

[10]
Primary Prevention With Statins in the Elderly.

J Am Coll Cardiol. 2018-1-2

引用本文的文献

[1]
Using secondary prevention strategies in patients after PCI: a narrative review.

Front Public Health. 2025-7-10

[2]
An Anti-Inflammatory Diet and Its Potential Benefit for Individuals with Mental Disorders and Neurodegenerative Diseases-A Narrative Review.

Nutrients. 2024-8-10

[3]
Advances in Clinical Imaging of Vascular Inflammation: A State-of-the-Art Review.

JACC Basic Transl Sci. 2023-12-13

[4]
The effects of simvastatin and fenofibrate on malondialdehyde and reduced glutathione concentrations in the plasma, liver, and brain of normolipidaemic and hyperlipidaemic rats.

Arh Hig Rada Toksikol. 2023-3-1

本文引用的文献

[1]
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice.

Eur Heart J. 2021-9-7

[2]
Editorial: Review Articles, Systematic Reviews, Meta-Analysis, and the Updated Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 Guidelines.

Med Sci Monit. 2021-8-23

[3]
SCORE2-OP risk prediction algorithms: estimating incident cardiovascular event risk in older persons in four geographical risk regions.

Eur Heart J. 2021-7-1

[4]
Health effects of climate change: an overview of systematic reviews.

BMJ Open. 2021-6-9

[5]
Colchicine in Patients with Chronic Coronary Disease.

N Engl J Med. 2020-8-31

[6]
Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction.

N Engl J Med. 2019-11-16

[7]
Lifestyle factors and high-risk atherosclerosis: Pathways and mechanisms beyond traditional risk factors.

Eur J Prev Cardiol. 2020-3

[8]
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia.

N Engl J Med. 2018-11-10

[9]
Nontraditional Risk Factors in Cardiovascular Disease Risk Assessment: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.

JAMA. 2018-7-17

[10]
2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR).

Atherosclerosis. 2016-9

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索